We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Intraoperative Frozen Section Detect Acute Invasive Fungal Rhinosinusitis

By LabMedica International staff writers
Posted on 09 Jun 2021
Print article
Image: (A) Mucormycetes demonstrated broad hyphae with wavy, nonparallel walls and few septa. (B) Nonmucormycetes, which were predominantly Aspergillus species by culture, demonstrated thin delicate hyphae with parallel walls and frequent septa. (C and D) Candida species were distinctive for a mixture of yeasts and pseudohyphae (Photo courtesy of UT Health San Antonio)
Image: (A) Mucormycetes demonstrated broad hyphae with wavy, nonparallel walls and few septa. (B) Nonmucormycetes, which were predominantly Aspergillus species by culture, demonstrated thin delicate hyphae with parallel walls and frequent septa. (C and D) Candida species were distinctive for a mixture of yeasts and pseudohyphae (Photo courtesy of UT Health San Antonio)
Acute invasive fungal rhinosinusitis (AIFRS) is a potentially lethal and rapidly progressive disease. It primarily affects immunocompromised or diabetic patients, in whom organisms that are ubiquitous, but usually harmless can invade mucosa and rapidly disseminate to the orbit and cranial cavity.

Diagnostic delay is a factor that has consistently been associated with poor outcome in AIFRS, and this, in part, is related to the fact that AIFRS remains a histopathologic diagnosis. The clinical features are nonspecific, and sinus computed tomography is limited by lack of sensitivity for early AIFRS and poor specificity thereafter.

Medical Laboratorians at the UT Health San Antonio (San Antonio, TX, USA) retrospectively reviewed all cases of clinically suspected AIFRS during a 10-year period. Frozen-section samples were received fresh from the operating room, embedded in optimal cutting temperature medium, and allowed to freeze within a cryostat at an approximate temperature of −20 °C. Biopsies were entirely embedded when size permitted. Sections were prepared using a Leica Biosystems cryostat (Nußloch, Germany), at a thickness of approximately 5 μm, across two different levels. These were stained with hematoxylin and eosin (H&E) and interpreted by the general surgical pathologist on-call for frozen sections. The frozen-section results were compared with the final permanent sections as well as the tissue fungal culture results, following which the accuracy of frozen section was determined.

The team reported that 48 patients with 133 frozen-section evaluations for AIFRS were included in the study. Thirty of 48 patients and 61 of 133 specimens were positive for AIFRS on final pathology. Of 30 positive patients, 27 (90%) had at least one specimen diagnosed as positive during intraoperative consultation; among the 61 positive specimens, 54 (88.5%) were diagnosed as positive during intraoperative consultation. Of 72 negative specimens, all were interpreted as negative on frozen section. Thus, frozen sections had a sensitivity of 88.5%, specificity of 100%, positive predictive value of 100%, and negative predictive value of 90.6%.

The authors concluded that the decision to undertake surgical debridement in patients with AIFRS requires definitive histopathologic diagnosis, for which intraoperative consultation with frozen section may be requested. Their analysis has demonstrated overall high accuracy of frozen sections in this scenario, and this information may be valuable in the surgical management of these patients. The study was published in the June, 2021 issue of the journal Archives of Pathology and Laboratory Medicine.

Related Links:
UT Health San Antonio
Leica Biosystems


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Cytomegalovirus Real-Time PCR Test
Quanty CMV Virus System
New
HbA1c Test
HbA1c Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: Professor Nicole Strittmatter (left) and first author Wei Chen stand in front of the mass spectrometer with a tissue sample (Photo courtesy of Robert Reich/TUM)

Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication

Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more

Molecular Diagnostics

view channel
Image: Macrophages infected with mycobacterium tuberculosis (Photo courtesy of MIT)

New Molecular Label to Help Develop Simpler and Faster Tuberculosis Tests

Tuberculosis (TB), the deadliest infectious disease globally, is responsible for infecting an estimated 10 million people each year and causing over 1 million deaths annually. While chest X-rays and molecular... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.